PCLS: An ex-vivo Window Into Lung Disease and Drug Discovery
Oct. 23, 2024
Courtesy ofSCIREQ - an emka TECHNOLOGIES Company
Precision-Cut Lung Slices (PCLS) have emerged as a innovative ex vivo model that allows researchers to explore deep into lung physiology, disease mechanisms, and pharmacological responses. By offering a unique combination of biological complexity and controlled experimental conditions, PCLS serve as a critical bridge between the limitations of traditional in vitro cell cultures and the complexities of in vivo models. The versatility and precision of this technique have positioned PCLS as an invaluable tool in advancing our understanding of lung diseases and accelerating the discovery of novel treatments.
Most popular related searches
lung disease
drug discovery
disease lung
lung tissue
lung cancer
idiopathic pulmonary fibrosis
sars-cov-2
COVID 19
pulmonary fibrosis
airway inflammation
lung infection
pulmonary disease
cancer cell
preclinical trial
lung functions
lung health
cancer tissue
fibrosis lung
disease mechanisms
lung functionality
pulmonary arterial
inflammation research
therapeutic development
anti-inflammatory
inflammatory compound
immune response
respiratory pathogen
arterial hypertension
tumor growth
tumor microenvironment
lung function
drug delivery
cancer treatment
cancer patient
rare disease
antibiotic resistance
Stay in the loop!
Select your areas of interest to receive industry updates.